Delivery Order SPE2DB20D3505-SPE2DB24FU5D4
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,694.71 firm fixed-price delivery order is for the supply of 4,562,470,814 units of 3 mg Doxepin HCL tablets, to be completed by October 16, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Doxepin HCL 3 mg tablets. The fixed-price, firm-fixed delivery order has a ceiling value of $2,261.61 and an ultimate completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,403.33, is for the delivery of Doxepin Hydrochloride 3 mg tablets in 30-count packages. The award is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 3 mg doxepin hydrochloride tablets in packages of 30, with a total ceiling value of $20,101.12 and a completion date of October 19, 2023. The contract is a firm fixed-price arrangement, with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,196.53, is for the delivery of 4,564,460,309 units of doxepin hydrochloride 3 mg tablets. The contract has an ultimate completion date of May 2, 2024 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $2,238.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 3 mg doxepin hydrochloride tablets, a medication used to treat mental health conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a...
This federal contract award is for the delivery of Doxepin HCL 3 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,729.85, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of January 12, 2024. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,685.12, is for the delivery of doxepin HCL 6 mg tablets. The contract has an ultimate completion date of December 15, 2023 and is a firm fixed-price delivery order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Doxepin Hydrochloride 3 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order, valued at $1,815.47, has an ultimate completion date of December 6, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. This award is part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...